These discoveries underscore the promise of GPR37 as a new therapeutic and radiotherapeutic target in ESCC, providing a possible treatment strategy and offering new insights for the clinical management of ESCC. The gene discussed is GPR37; the disease is esophageal squamous cell carcinoma.